Literature DB >> 18989897

Potential of different techniques of preferential crystallization for enantioseparation of racemic compound forming systems.

Daniel Polenske1, Heike Lorenz, Andreas Seidel-Morgenstern.   

Abstract

Recently the feasibility of preferential crystallization for enantioseparation of racemic compound forming systems has been demonstrated (Lorenz et al., Application of preferential crystallization to resolve racemic compounds in a hybrid process. Chirality 2006;18:828-840; Polenske et al., Separation of the propranolol hydrochloride enantiomers by preferential crystallization: thermodynamic basis and experimental verification. Cryst Growth Des 2007;7:1628-1634). Here, the development and the potential of an efficient separation process operated via two different techniques of preferential crystallization are studied: (1) seeded isothermal preferential crystallization and (2) auto-seeded polythermal preferential crystallization. Both techniques were investigated in the batch and in the cyclic operation mode. On the example of mandelic acid as a typical racemic compound forming system, it is demonstrated that a cyclic auto-seeded polythermal process is feasible and significantly more efficient than the seeded isothermal one. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Year:  2009        PMID: 18989897     DOI: 10.1002/chir.20672

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  2 in total

1.  Enantioseparation by crystallization using magnetic substrates.

Authors:  Francesco Tassinari; Jakob Steidel; Shahar Paltiel; Claudio Fontanesi; Meir Lahav; Yossi Paltiel; Ron Naaman
Journal:  Chem Sci       Date:  2019-04-10       Impact factor: 9.825

2.  Direct Crystallization Resolution of Racemates Enhanced by Chiral Nanorods: Experimental, Statistical, and Quantum Mechanics/Molecular Dynamics Simulation Studies.

Authors:  Jiaojiao Cao; Boxuan Lou; Yue Xu; Xiaolan Qin; Haikuan Yuan; Lijuan Zhang; Yan Zhang; Sohrab Rohani; Jie Lu
Journal:  ACS Omega       Date:  2022-06-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.